Ulrike Korf's Biography

Ulrike Korf, Senior Scientist/Group Leader, German Cancer Research Center

Dr. Ulrike Korf has established reverse phase protein arrays (RPPA) at the German Cancer Research Center (DKFZ) in Heidelberg, Germany. She is using this RPPA as technology for targeted proteomics and in various projects ranging from biomarker discovery over drug validation to systems biology approaches.

Use of Reverse Phase Protein Arrays to Elucidate Impact of Targeted Drugs on Signaling Networks

Monday, 10 March 2014 at 11:30

Add to Calendar ▼2014-03-10 11:30:002014-03-10 12:30:00Europe/LondonUse of Reverse Phase Protein Arrays to Elucidate Impact of Targeted Drugs on Signaling Networks Advances in Microarray Technology in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com

Analyzing signaling network dynamics upon exposure to targeted drugs might allow insights into drug response and resistance mechanisms. Using reverse phase protein microarrays (RPPA) as experimental platform, quantitative proteomic data were generated by exposing human breast cancer cell lines to targeted drugs such as trastuzumab.

Add to Calendar ▼2014-03-10 00:00:002014-03-11 00:00:00Europe/LondonAdvances in Microarray TechnologyAdvances in Microarray Technology in Berlin, GermanyBerlin, GermanySELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors